MAPT and Alzheimer disease: As a designed GSK3β inhibitor, compound 10a has shown comprehensive anti‐AD effects in AlCl3 combined with d‐galactose induced AD mice, including improved cognitive ability, reduced tau hyperphosphorylation, and lowered hippocampal neuronal damage, among others.246